Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - ARRAY BIOPHARMA INC | a06302017ex312.htm |
| EX-31.1 - EXHIBIT 31.1 - ARRAY BIOPHARMA INC | a06302017ex311.htm |
| EX-23.1 - EXHIBIT 23.1 - ARRAY BIOPHARMA INC | a06302017ex231.htm |
| EX-10.82 - EXHIBIT 10.82 - ARRAY BIOPHARMA INC | boulderlease2ndamendment.htm |
| EX-10.81 - EXHIBIT 10.81 - ARRAY BIOPHARMA INC | clinicaltrialagmt.htm |
| EX-10.80 - EXHIBIT 10.80 - ARRAY BIOPHARMA INC | onolicenseagreementredacted.htm |
| 10-K - 10-K - ARRAY BIOPHARMA INC | a06301710-k.htm |
Exhibit 32.1
CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with this annual report of Array BioPharma Inc. (the “Registrant”) on Form 10-K for the period ended June 30, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the date indicated below, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
(a) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
(b) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant. |
Date: | August 11, 2017 | /s/ RON SQUARER |
Ron Squarer | ||
Chief Executive Officer | ||
/s/ JASON HADDOCK | ||
Jason Haddock | ||
Chief Financial Officer | ||